Another anticoagulant available for thromboprophylaxis is fondaparinux, an indirect inhibitor of activated factor X. In a double-blind, non-inferiority trial of 2,927 patients undergoing high-risk ...

ECIM 2025 saw a heated discussion on whether anticoagulation in DVT should be treated like a chronic condition, as new ...

The following is a summary of “Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: ...

Of 32 reports of anticoagulant therapy for acute myocardial infarction, appraised to ascertain the maintenance of eight methodologic standards that affect the scientific comparability of treated ...

PERIXa protocol shows minimal bleeding risk in AF patients, ensuring safe anticoagulation management for minor procedures.

OAC is the cornerstone therapy for stroke prevention in people ... also expands the concept to the more contemporary direct oral anticoagulants (DOACs) used in Afib. "This changes the message ...

Researchers determined further improvements are necessary to better capture clinically useful data in a pediatric population for DOAC trials.

Michael Ke Wang, M.D., from McMaster University in Hamilton, Ontario, Canada, and colleagues estimated the differences in bleeding risks between therapeutic-dose nonvitamin K oral anticoagulants ...